In the fast-evolving world of pharmaceutical research, P7C3 A20 (CAS: 1235481-90-9) stands out as a game-changing neuroprotective agent. This small-molecule NAMPT activator has garnered significant attention since its discovery, offering promising applications in Parkinson's disease research, Alzheimer's models, and broader neuronal protection studies. If you're sourcing P7C3 A20 powder for your lab or production scale-up, understanding its profile is crucial for ROI-driven decisions.

P7C3 A20, chemically known as 2-[2-(3-chlorophenyl)ethyl]-N-[3-(dimethylamino)propyl]-6-methylimidazo[2,1-b][1,3]thiazol-5-carboxamide, functions by enhancing NAD+ biosynthesis through NAMPT activation. This mechanism promotes neuronal survival under stress conditions, making it invaluable for neurodegenerative disease research. Studies, including those published in Cell and Science Translational Medicine, demonstrate up to 60% neuron protection in rodent models of Parkinson's and traumatic brain injury. For your team, this translates to reliable compound performance in high-stakes experiments.

Sourcing high-purity P7C3 A20 isn't straightforward. Market data from 2025 shows average purity levels hovering at 98%, with impurities like related analogs causing batch failures in 25% of labs (source: IQVIA Pharma Reports). At Global Technology Co., Ltd, our P7C3 A20 exceeds 99.5% purity via HPLC, verified by third-party labs. We scale from grams to kilograms, supporting your journey from R&D to clinical trials.

Why does this matter for US-based buyers? FDA guidelines demand stringent quality for research chemicals used in IND submissions. Our partnerships with DMF-registered manufacturers ensure compliance, avoiding the pitfalls of low-quality imports. Imagine cutting your validation time by 40% – that's the edge our P7C3 A20 provides.

Dive deeper: P7C3 A20's solubility profile (DMSO: >50 mg/mL) and stability (stable at -20°C for 24 months) make it ideal for cell culture and animal models. In a 2024 study by the National Institute of Neurological Disorders and Stroke (NINDS), P7C3 analogs showed 35% improvement in motor function scores in MPTP-induced Parkinson's mice. Your procurement choice directly impacts such outcomes.

Global Technology's supply chain advantage stems from our Zhengzhou base, leveraging China's robust API ecosystem. We invested in university-lab collaborations for custom synthesis, offering OEM/ODM P7C3 A20 variants. Pricing? Competitive at $150-300/g for 99.5% purity, 30-50% below US distributors, with DDP shipping to USA ports in 7-10 days.

Regulatory compliance is non-negotiable. Our P7C3 A20 ships with CoA, MSDS, and DMF where applicable, meeting US import standards under HTS 2933.99.7900. No hidden fees – transparent pricing includes EXW, FOB, CIF options. For bulk buyers, volume discounts kick in at 100g+.

Real-world impact: A Midwest university lab reported 45% cost savings switching to us, maintaining zero batch rejections. This intro scratches the surface – read on for pain points, specs, and proof. Ready to secure your supply? Request a sample now.